Minerva Neurosciences, Inc
NERV
Last
$3.18
Day
-1.2%
1y
+25.3%
5y
-74.5%
52w
-74.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0425d
EMA 21
3.54
EMA 50
3.94
EMA 200
4.43
20d high
-26.6%
5y high
-78.9%
5y range
15th
Positions held
Your positionsNERV isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$3.63
Stop
$2.88
Stop distance
9.4%
Target vs last
+14.2%
Fundamentals
| Market cap | $153.75M | Enterprise value | $150.22M | Trailing P/E | — | Forward P/E | -7.67 |
| PEG | — | Price / book | -0.71 | Beta | -0.12 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | -28.4% | Debt / equity | — |
| Current ratio | 20.14 | Free cash flow | -$8.86M | Analyst recommendation | none | Mean target | $10.33 |
| 52w high | $12.46 | 52w low | $2.24 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | $17.5M | -$125M | -$284M | -$2.7M | -$3.3M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$10.6M | -$16.7M | -$5.0M | -$2.8M | -$3.4M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$293M | $1.4M | -$30.0M | -$32.1M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$15.1M | -$21.8M | -$23.1M | -$25.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsNERV · daily-15.5% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin